UBS Group
PLSE icon

UBS Group’s Pulse Biosciences PLSE Stock Holding History

UBS Group’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,800
Closed -$66.2K – 10603
2024
Q4 		$66.2K Sell
3,800
-10,000
-72% -$176K ﹤0.01% 7124
2024
Q3 		$242K Buy
+13,800
New +$235K ﹤0.01% 5732

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

UBS Group's PLSE Position: Q2 2026 in Review

UBS Group increased its Pulse Biosciences (PLSE) stake by 712% in Q2 2026, buying an estimated $5.7M and bringing the position to 275,669 shares worth $7.64M. The position accounts for ﹤0.01% of the portfolio, ranked #3746.

UBS Group first reported a position in PLSE in Q2 2016 and has held it in 37 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • UBS Group held 275,669 shares of Pulse Biosciences worth $7.64M as of Q2 2026.
  • UBS Group bought 241,715 Pulse Biosciences shares in Q2 2026, an estimated $5.7M.
  • Pulse Biosciences made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3746 holding.
  • UBS Group first reported a position in Pulse Biosciences in Q2 2016 and has held it in 37 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.